Single IMA {Single Arterial}

Slides:



Advertisements
Similar presentations
Allen Jeremias MD MSc, Sanjay Kaul MD, Luis Gruberg MD, Todd K. Rosengart MD, David L. Brown MD Divisions of Cardiovascular Medicine and Cardiothoracic.
Advertisements

STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
In Diabetics with Ischemic Heart Disease CABG revascularization is always superior? Dr. Paolo Ferrazzi.
Long-term predictive value of assessment of coronary atherosclerosis by contrast- enhanced coronary computed tomography angiography: meta- analysis and.
5 Years Results of Off-Pump VS On-Pump CABG 5 Years Results of Off-Pump VS On-Pump CABG Prospective Non-randomized Comparative Study Piya Cherntanomwong*,
Factors influencing treatment decisions for coronary artery disease after cardiac catheterization American Heart Association November 18, 2013 Dallas,
Preservation Solutions, Vein Graft Patency, and Outcomes after Coronary Bypass Surgery RE Harskamp, JH Alexander, PJ Schulte, CM Brophy, MJ Mack, ED Peterson,
The Radial Artery Patency Study Investigators Radial Artery and Saphenous Vein Patency more than 5-years Following Coronary Artery Bypass Surgery: Results.
Coronary Artery Disease in Diabetic Patients, Different from Non-diabetics?
PPAR  activation Clinical evidence. Evolution of clinical evidence supporting PPAR  activation and beyond Surrogate outcomes studies Large.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
How Many Arterial Grafts is Enough?
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
André Lamy Population Health Research Institute Hamilton Health Sciences McMaster University Hamilton, CANADA on behalf of the CORONARY Investigators Disclosures.
André Lamy Population Health Research Institute Hamilton Health Sciences McMaster University Hamilton, CANADA on behalf of the CORONARY Investigators Disclosures.
Background Current guideline recommend an early invasive strategy for NSTEMI patients (Class IIA). However, 67% US hospitals have no catheterization capability.
Impact of Drug-Eluting Stents on Revascularization Choices in Patients with Acute Coronary Syndromes and Multivessel Coronary Disease: Results from the.
Disclosures The presenter has no financial involvement with the product or competing products being discussed. The presenter received travel and lodging.
Evidence for a Survival Benefit Conferred by Adjuvant Radiotherapy in a Cohort of 608 Women with Early-stage Endometrial Cancer O. Kenneth Macdonald 1,
Are all forms of total arterial revascularisation equal? A comparison of single versus bilateral internal thoracic artery grafting strategies. William.
Gregg W. Stone MD for the ACUITY Investigators Gregg W. Stone MD for the ACUITY Investigators A Prospective, Randomized Trial of Bivalirudin in Acute Coronary.
STICH CABG Objective To determine whether surgery plus medical management or medical management alone improve outcomes in CABG patients Study Design 1212.
DIABETES INSTITUTE JOURNAL CLUB CARINA SIGNORI, D.O., M.P.H. DECEMBER 15, 2011 Atherothrombosis intervention in metabolic syndrome with low HDL/High Triglycerides:
Gregg W. Stone MD for the ACUITY Investigators A Prospective, Randomized Trial of Bivalirudin in Acute Coronary Syndromes Final One-Year Results from the.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Department of cardiovascular surgery Kumamoto Central Hospital Taro Nakatsu, Nobushige Tamura, Takuya Nomoto, Koji Hagio, Masanosuke Ishigami, Shouichi.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Objective Bleeding events are grave and sometimes life threatening complications after prosthetic valve replacement, especially in hemodialysis patients.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
From: Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med.
1-year Outcome of The Italian Registry on Chronic Total Occlusion:
When Using DOPPS Slides
Lako S, Daka A, Nurka T, Dedej T, Memishaj S
John Weeks1, MD Candidate 2017, Justin Hickman1, MD Candidate 2017
Thirty-day Readmissions Following CABG Surgery in New York JACC: Cardiovascular Interventions 2011;4(5): Hannan EL, Zhong Y, Lahey SJ, Culliford.
MedStar Washington Hospital Center Cardiac Catheterization Conference
The Evidence For Conduit Choice
CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump
Long-Term Forecasting and Comparison of Mortality in the Evaluation of the Xience Everolimus-Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness.
Saphenous Vein Grafts with Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass Surgery: One-Year Graft Failure and Five-Year.
Clinical outcome after SVR: Veterans Affairs
POISE-2 PeriOperative ISchemic Evaluation-2 Trial
PS Sever, PM Rothwell, SC Howard, JE Dobson, B Dahlöf,
RAAS Blockade: Focus on ACEI
Samir R. Kapadia, MD On behalf of The PARTNER Trial Investigators
Diabetes mellitus in patients undergoing percutaneous drug-eluting stent implantation: short and long-term results Claudio Moretti, M.D. Division of Cardiology,
Mean eGFR among survivors after CABG surgery vs all-cause deaths
Section 7: Aggressive vs moderate approach to lipid lowering
Coronary Artery Surgery
Dr. PJ Devereaux on behalf of POISE Investigators
Predicting In-Hospital Mortality After Redo Cardiac Operations: Development of a Preoperative Scorecard  Sebastian Launcelott, BA, BComm, Maral Ouzounian,
Impact of clopidogrel loading dose on the safety and effectiveness of bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction:
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Impact of Platelet Reactivity Following Clopidogrel Administration
Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G
for the REGROUP Trial Investigators
Dr. PJ Devereaux on behalf of POISE Investigators
Anemia Is Associated With Increased One-Year Mortality and Ischemic Events in Patients With ACS: Results From the ACUITY Trial Steven V. Manoukian, George.
Satya Shanbhag Waikato Cardiothoracic Unit
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Long-term outcome of revascularization with composite T-grafts: Is bilateral mammary grafting better than single mammary and radial artery grafting? 
Impact of Diabetes Mellitus on Long-term Outcomes in the
Melissa Herrin, Jan Tate ScD, MPH & Amy Justice, MD, PhD
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
Baseline Characteristics
Atlantic Cardiovascular Patient Outcomes Research Team
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
Axillary-Bi-Femoral and Axillary-Uni-Femoral Artery Grafts Have Similar Perioperative Outcomes and Patency Thomas W. Cheng1, M.S., Scott Hardouin1, M.D.,
Presentation transcript:

Single IMA {Single Arterial} Bi-Lateral Internal Mammary Artery (BIMA) Grafting Confers Improved Long-Term Survival After CABG Surgery Compared to Single IMA Grafting Ryan P Kelly, Karen J Buth, Jean-Francois Légaré Dalhousie University, Faculty of Medicine, Division of Cardiac Surgery, Halifax, Nova Scotia, Canada Grafting Strategy Long-Term Results BACKGROUND: The primary objective of this study was to examine the effect of different arterial grafting strategies in CABG surgery on long-term mortality. METHODS: All consecutive CABG surgeries excluding redo operations performed at a single tertiary care center between 1995-2007 were reviewed. Long-term survival rates were compared among patients based on the use of no arterial graft (all saphenous vein), single arterial graft, and multiple arterial grafts. Groups were also stratified based on the type of arterial grafts used (bilateral internal mammary arteries (BIMA) vs. multiple arterial grafts with only one IMA). Cox proportional Hazards ratio models were generated to adjust for differences in clinical presentation between the CABG groups. RESULTS: A total of 8570 isolated CABG operations were preformed at our institution during that period. These patients were followed for a median time of 3.5 years (IQR=1.1-6.4). In this patient population, a single arterial graft was performed in the majority of patients (63%; n=5637) with 28% of patients (n=2532) receiving multiple arterial grafts. Patients who received multiple arterial grafts were more likely to be young, male, and undergo non-urgent surgery. After adjusting for these differences, patients who received any arterial graft were shown to have improved survival when compared to patients who did not (HR=0.75; CI=0.65-0.85). However when single arterial grafts were compared to multiple arterial grafts no incremental survival benefit was apparent except for BIMA use. Among patients who received multiple arterial grafts, percent survival for patients with BIMA grafts at 10 years was 71.6% compared to 66.6% for multiple arterial without BIMA and 66.5% for patients with single arterial grafts (p<0.0001). CONCLUSIONS: We were able to show that after adjusting for differences in clinical presentation multiple arterial grafting, specifically with BIMA grafting, is a strong independent predictor of long-term survival among CABG patients. This observation emphasizes the benefit of BIMA grafting, and suggests that in suitable candidates BIMA grafting should be considered the ideal revascularization strategy. Impact of BIMA Grafting on Survival Adjusted for Clinical Characteristics Impact of BIMA Grafting on Readmission Adjusted for Clinical Characteristics 8570 Isolated CABG 1995-2007 5437 Single Arterial Graft 2448 Multiple Arterial Grafts 685 SVG Only 1079 BIMA Grafts 1369 IMA + Other Background CABG surgery is the established treatment for LM and multi- vessel CAD with excellent short and intermediate-term outcomes Long-term results affected by vein-graft failure: Intimal hyperplasia Graft atherosclerosis Strong evidence supports LIMA to LAD due to: Superior graft patency Fewer cardiac events Enhanced survival compared to SVG alone Is there survival advantage for bilateral internal mammary artery (BIMA) over Single IMA? ] BIMA BIMA * Single IMA Single IMA ] ] * * SVG Only SVG Only SVG Only Single IMA BIMA 5 Year 82% (± 3%) 86% (± 2%) 88% (± 2%) 10 Year 59% (± 5%) 66% (± 4%) 71% (± 4%) SVG Only Single IMA BIMA 5 Year 77% (± 4%) 83% (± 3%) 85% (± 3%) 10 Year 59% (± 6%) 68% (± 5%) 72% (± 5%) 6806 Single IMA Number of patients at risk 1079 976 845 575 414 231 BIMA 6806 5661 4501 3172 1954 979 Single IMA 685 494 374 251 177 106 SVG Only Number of patients at risk 1061 904 737 473 317 171 BIMA 6664 5176 3863 2547 1468 671 Single IMA 638 428 299 172 116 66 SVG Only Univariate Analysis Arterial Grafting Adjusted Hazard Ratio 95% CI p - value BIMA 0.81 (0.68-0.98) 0.0260 SVG Only 1.34 (1.17-1.53) 0.0001 Arterial Grafting Adjusted Hazard Ratio 95% CI p - value BIMA 0.86 (0.73-1.01) 0.0580 SVG Only 1.39 (1.17-1.64) 0.0002 Grafting Strategy Methods All consecutive CABG surgeries excluding redo surgery performed at a single tertiary care center between 1995-2007 were reviewed Univariate analysis of clinical characterstics by grafting strategy Rate of long-term survival and readmission for cardiac cause were compared based on grafting strategy Cox proportional hazards models were generated to adjust for differences in clinical characteristics between groups Clinical Characteristics SVG Only n = 685 (%) Single IMA {Single Arterial} n = 5437 (%) Single IMA {IMA + other} n = 1369 (%) BIMA n = 1079 (%) p - value Mean Age (SD) 70.2 (10.4) 65.5 (10.1) 62.0 (10.1) 58.5 (10.0) <0.0001 Incomp Revasc 26.4 19.7 17.9 12.0 Female 34.9 26.6 18.6 18.0 BMI > 35 9.6 11.4 11.3 9.1 Diabetes 34.5 36.9 37.0 25.6 Renal Failure 12.3 5.5 3.0 1.8 PVD 25.0 16.8 14.3 CVD 16.6 13.9 10.2 9.4 COPD 23.2 14.2 12.9 10.7 EF < 40% 23.1 12.7 8.0 7.2 CHF 25.4 14.5 9.3 6.4 Urgent Status 36.2 16.1 10.0 9.7 LAD Disease 76.8 94.8 93.1 94.0 LAD Graft 71.8 98.1 96.1 96.5 Conclusions Compared to the use of a single IMA or vein grafting alone, BIMA grafting independently predicts a long-term survival advantage and a significant reduction in the rate of readmission to hospital for cardiac cause including ACS, PCI, or CABG In suitable candidates, BIMA grafting should be considered the ideal revascularization strategy